The latest myeloma news, all in one place. Find research updates, expert interviews, and more on SOHO Insider, including coverage from SOHO 2026. Go to sohoinsider.com/category/mul...
@societyofhemonc.bsky.social
@societyofhemonc.bsky.socialThe latest myeloma news, all in one place. Find research updates, expert interviews, and more on SOHO Insider, including coverage from SOHO 2026. Go to sohoinsider.com/category/mul...
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVqzpq
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.
@ertrunnell.bsky.socialRead NHLBI's full Oct 6 guidance here:
www.nhlbi.nih.gov/about/leader...
#NHLBI #cardiosky #vascularsky #pulmsky #hemesky #hematology
@iahadupdates.bsky.socialIAHAD 39th Webinar: Thrombocytopenia and Coagulation Abnormalities in Critical Care
Talk: Prof. Jecko Thachil
Moderator: Dr. Abhay Bhave
Panelists:
Dr. Rajat Raja
Dr. Nikhil M Kumar
Fri, 9 Oct 2026 | 6:30–8:00 PM IST
Register: miceideas.org/webinar/regi...
@stanford-heme.bsky.socialWe’re thrilled to welcome Jean M. Connors, MD to Stanford tomorrow for our Breakthroughs in Hematology Seminar Series!
We look forward to an inspiring afternoon of discovery and conversation.
@ashclinicalnews.bsky.socialThe October issue is out now! Highlights include a feature on the #healthcare and practice issues at stake in the U.S. midterms, collaboration between #hematology and #cardiology in the management of AL #amyloidosis, and more. Check out the full lineup 👉 https://ow.ly/mJwE50ZV3r3
@theebmt.bsky.social💬 At #ITCTC26, experts and trainees from around the world discussed topics spanning haematological and oncological diseases, immunological disorders, and challenging clinical cases, fostering a valuable knowledge exchange across borders: www.ebmt.org/ebmt/news/11...
@theebmt.bsky.social📣 The EBMT Trainee Committee is welcoming new members to join a collaborative team of early-career professionals and young haematologists.
🔎 Learn more about the opportunity to amplify your impact and make sure to apply by 6 November: ebmt.org/ebmt/news/ap...
@societyofhemonc.bsky.social📢 Registration is open for the 4th SOHO-Israel Meeting! Nov 19–20, 2026, in person or online.
Register: hematology2026.forms-wizard.biz
Read more: sohoinsider.com/.../4th-soho...
#SOHO #Hematology #Oncology
@ash.hematology.org🚨 The hematology boards are almost here! 🚨
Join the ASH Hematology Review Series for expert lectures, live sessions, and more! Enroll now: https://ow.ly/s4er50ZRt0T
@tenuretracker.bsky.socialUniversity of California, Irvine (UCI) (@ucirvine.bsky.social) is hiring:
Health Sciences Clinical Professor Series (Hematology/Oncology) – Open Ranks
@hemehub.bsky.social🩸Happening next week!
⮕ Register: hemehub.org/live-webinars
⮕ Submit your cases: hemehub.org/case-submiss...
#AcuteIntermittentPorphyria #AIP #Porphyria #RareDiseases #Hematology #HemeOnc #ClinicalHematology #MedicalEducation #HemeHub
@utmbhealth.bsky.social
@eshaematology.bsky.socialA friendly get together to close #ESHCML2026 1st day. Poster Viewing & informal scientific exchange between colleagues and friends. See you tomorrow at 7:30 am!
@jcortesmd.bsky.social, Tim P. Hughes, D. S. Krause
#ESHCONFERENCES @icmlf.bsky.social #CMLsm #ESHYOUNGREPORTERS #HAEMATOLOGY #HEMATOLOGY
@ash.hematology.orgAdvancing #hematology takes collaboration. Through the ASH Corporate Friends program, participating companies help support transformative research, innovative education, and high-quality, equitable care.
Learn more: https://ow.ly/VV6L50ZTVZk
Thank you to all participating companies!
@hemehub.bsky.social🩸Our case discussion on Smoldering Multiple Myeloma with Shaji Kumar, MD and Adeel Khan, MD is now available to watch on YouTube!
⮕ Watch the full session: youtu.be/vbFJmFe0vjE?...
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
@onclive.bsky.social🎙️ In case you missed any, read a recap of the episodes of #OncliveOnAir that aired in September 2026. @lpetrillz.bsky.social @matthewkurianmd.bsky.social #oncology #hematology
Read the full recap ➡️: www.onclive.com/view/revisit...
@ash.hematology.orgThe 2027 Highlights of ASH are coming to cities around the world!
Following #ASH26, leading experts will explore what the latest #ASH26 findings mean for clinical practice and patient care in your region.
Register today: https://ow.ly/5pms50ZTtI7
@ash.edu.hematology.org🎧 New Episode Alert! 🎧🎙️ Listen now to the new episode of HemeTalks: Conversations in Hematology Education on From Aplastic Anemia to PNH: The Patient Perspective! #HemeTalks #MedicalPodcast #Hematology
@hemehub.bsky.socialExplore the latest insights on Acute Intermittent Porphyria with Dr. Karl E. Anderson and Dr. Taha Bat in our upcoming live webinar!
⮕ Register: hemehub.org/live-webinars
⮕ Submit your cases: hemehub.org/case-submiss...
#AcuteIntermittentPorphyria #AIP #Porphyria #RareDiseases #Hematology
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVhmxL
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.